Kathryn A. Lysko

Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger.

Tianli Yue, Paul G. Lysko, Patrick McKenna et al. · Journal of Pharmacology and Experimental Therapeutics · 1992 · 481 citations

Calorimetric studies of the structural transitions of the human erythrocyte membrane. The involvement of spectrin in the A transition

John F. Brandts, Leif Erickson, Kathryn A. Lysko et al. · Biochemistry · 1977 · 200 citations

Biomedical Research, Altmetric Attention Score, Cellular Physiology +17

Protein involvement in structural transitions of erythrocyte ghosts. Use of thermal gel analysis to detect protein aggregation

Kathryn A. Lysko, Robert Carlson, Richard D. Taverna et al. · Biochemistry · 1981 · 78 citations

Neuroprotective effects of carvedilol, a new antihypertensive agent, in cultured rat cerebellar neurons and in gerbil global brain ischemia.

Paul G. Lysko, Kathryn A. Lysko, Tingting Yue et al. · Stroke · 1992 · 77 citations · Full text

SB 211475, a metabolite of carvedilol, a novel antihypertensive agent, is a potent antioxidant

Tianli Yue, Patrick McKenna, Paul G. Lysko et al. · European Journal of Pharmacology · 1994 · 73 citations

Hypertension, Oxysterol, Biochemistry +9